# Gonorrhoea and Syphilis Cases Surge to Record Highs Across Europe
Gonorrhoea and syphilis cases have reached unprecedented levels across Europe, driven by gaps in testing infrastructure and prevention programs, according to a report from the European health agency.
The surge reflects a breakdown in sexual health services that intensified during the pandemic and has not fully recovered. Testing capacity remains constrained in many countries, leaving infections undiagnosed and untreated. Prevention campaigns have lost momentum, and public awareness about STI risks has declined significantly.
Antibiotic-resistant gonorrhoea strains compound the crisis. These variants reduce treatment effectiveness and raise the prospect of untreatable infections spreading through populations. Healthcare systems lack sufficient surveillance mechanisms to track resistance patterns in real time.
Syphilis transmission has accelerated particularly among men who have sex with men, though heterosexual transmission also increased. Early-stage syphilis cases went underdiagnosed because routine screening programs contracted. Late-stage syphilis, which causes severe organ damage and neurological complications, has reemerged in several countries after years of decline.
The health agency warns that current resources fall far short of what's needed. Mobile testing units remain limited. Patient education about condom use and regular screening has deteriorated. Contact tracing, critical for stopping transmission chains, operates inconsistently across borders.
Healthcare workers report patient backlogs that delay diagnosis by weeks or months. By that time, infected individuals transmit the diseases further. Sexual health clinics operate at reduced capacity in many regions due to budget cuts and staffing shortages.
Recovery requires immediate investment in laboratory capacity, trained personnel, and public awareness campaigns targeting high-risk groups. Without intervention, experts predict infections will continue climbing through 2024 and beyond.